You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Short report
Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 202026126172
Jul 2020636319
Aug 2020262612
Sep 2020474715
Oct 2020242413
Nov 202025256
Dec 2020888826
Jan 202182827
Feb 202191919
Mar 202113113112
Apr 20211021025
May 20211021026
Jun 20211011015
Jul 20211181188
Aug 20211021028
Sep 20211031037
Oct 202111011023
Nov 202111111019
Dec 20211191193
Jan 20221111145
Feb 202286865
Mar 2022303012
Apr 202228307
May 202223237
Jun 202253579
Jul 202278792
Aug 2022525213
Sep 2022575918
Oct 202245455
Nov 202245479
Dec 202247474
Jan 202343435
Feb 202365653
Mar 202339403
Apr 202339394
May 202342424
Jun 202338380
Jul 202340409
Aug 202346463
Sep 202342421
Oct 202340405
Nov 202348482
Dec 202358586
Jan 202416172
Feb 202430309
Mar 2024434369
Total30903105496